Spine

Aurora Spine Announces New Chief Financial Officer

CARLSBAD, Calif., Dec. 17, 2019 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSX VENTURE:ASG) announced the appointment of Jana F. Kiena as their Chief Financial Officer (CFO), effective December 17, 2019.

Ms. Kiena will help guide and oversee the company’s continued market leadership and financial growth. She brings more than 25 years of experience to Aurora Spine.

Ms. Kiena began her career with Arthur Anderson and has managed accounting operations in large, mid-sized and start-up companies, both publicly traded and private. Ms. Kiena earned a Bachelor of Science in Accounting from San Diego State University.

Former CFO Sarina Mason resigned from the Company effective December 16, 2019 to pursue other opportunities.

“We’re excited to welcome Jana to the Aurora Spine leadership team as we continue to focus on driving revenue growth and expanding profitability as our new CFO,” said Aurora Spine President and CEO, Trent J. Northcutt. “Jana brings extensive financial, operational, and strategic experience. This, combined with her deep knowledge of public markets, med-technology and experience scaling high-growth companies, will be a huge asset to Aurora Spine as we enter our next phase of growth and further our mission to Simplify the Complex.” He added, “I would like to thank outgoing CFO Sarina Mason for her contributions to the Company.”

About Aurora Spine

Aurora Spine is an early stage company focused on bringing new solutions to the spinal implant market through a series of screwless, innovative, minimally invasive, regenerative spinal implant technologies.  Aurora Spine continues to position itself at the forefront of spinal surgery procedures, focusing on minimally invasive spine surgery technologies.  Aurora Spine is changing spine surgery by focusing on disruptive technologies following the Company’s commitment to – Simplifying the Complex.

Forward-Looking Statements

This news release contains forward-looking information that involves substantial known and unknown risks and uncertainties, most of which are beyond the control of Aurora Spine, including, without limitation, those listed under “Risk Factors” and “Cautionary Statement Regarding Forward-Looking Information” in Aurora Spine’s final prospectus (collectively, “forward-looking information”). Forward-looking information in this news release includes information concerning the proposed use and success of the company’s products in surgical procedures. Aurora Spine cautions investors of Aurora Spine’s securities about important factors that could cause Aurora Spine’s actual results to differ materially from those projected in any forward-looking statements included in this news release. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ unilaterally from those expressed in such forward-looking statements. No assurance can be given that the expectations set out herein will prove to be correct and, accordingly, prospective investors should not place undue reliance on these forward looking statements. These statements speak only as of the date of this press release and Aurora Spine does not assume any obligation to update or revise them to reflect new events or circumstances.

For more information, please contact:

Aurora Spine Corporation

Trent Northcutt
President and Chief Executive Officer
(760) 424-2004

Jana F. Kiena
Chief Financial Officer
(760) 424-2004

www.aurora-spine.com

Print Friendly, PDF & Email
Tags

Mike Adams

Mike Adams is a medical device sales leader with extensive clinical experience in spine and biologics and a nationwide distribution network built over the last 10+ years in the industry. He has held various leadership positions in healthcare and device including Distributor Partner, Hospital COO and Spine VP of Sales. He currently leads the commercialization strategy for OrthoSpine Partners and is a Distributor Principal at Novel Medical. Because of his unique career path, Mike has the ability to see the healthcare business from multiple perspectives making him passionate about building strategic partnerships that help reduce overall costs, drive innovation, and cultivate growth for new markets.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close